Kevin Lalande is the Founding Managing Director and Chief Investment Officer of Santé Ventures. See sector focus and contact routes.
Kevin Lalande is the Founding Managing Director and Chief Investment Officer of Santé Ventures, a healthcare and life science venture capital firm he co-founded in Austin, Texas in 2006 that now manages over $1 billion across five funds [1][9]. His investment thesis focuses exclusively on early-stage healthcare and life sciences companies, primarily within the United States, leveraging his background as a former Austin Ventures investor and McKinsey consultant [1][8]. While specific check sizes and lead/follow behavior are not publicly detailed, the firm’s fifth fund closed at $330 million in early 2026, indicating substantial capacity for significant early investments [5]. Notable portfolio companies under his leadership include LDR Medical (acquired by Zimmer Biomet), Explorys (acquired by IBM), AbVitro (acquired by Bristol Myers Squibb), and Molecular Templates (Nasdaq: MTEM) [1][9]. Lalande holds an MBA from Harvard Business School where he was a Baker Scholar and also earned a graduate certificate in Artificial Intelligence from Stanford, which informs his approach to applying AI in investment strategies [1][9]. There is no publicly available record of distinctive public writi
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Austin.
Investors like Kevin Lalande · Full investor directory · Investor access · Company funding database